{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:00:01Z","timestamp":1781607601050,"version":"3.54.5"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10557-025-07761-7","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:24:29Z","timestamp":1755926669000},"page":"809-810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment on: \u201cModerate-Intensity Atorvastatin and Ezetimibe Combination Therapy Versus High-Intensity Atorvastatin in Patients with Angina Pectoris Who Underwent Percutaneous Coronary Intervention\u201d"],"prefix":"10.1007","volume":"40","author":[{"given":"Shaoxiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6281-2367","authenticated-orcid":false,"given":"Peili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"7761_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07729-7","author":"SY Sohn","year":"2025","unstructured":"Sohn SY, Kim YJ, Doh JH, Cho SW. Moderate-intensity atorvastatin and ezetimibe combination therapy versus high-intensity atorvastatin in patients with angina pectoris who underwent percutaneous coronary intervention. Cardiovasc Drugs Ther. 2025. https:\/\/doi.org\/10.1007\/s10557-025-07729-7.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"7761_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s43586-023-00249-4","volume":"3","author":"JK Hu","year":"2023","unstructured":"Hu JK, Tchetgen Tchetgen EJ, Dominici F. Using negative controls to adjust for unmeasured confounding bias in time series studies. Nat Rev Methods Primers. 2023;3(1):66. https:\/\/doi.org\/10.1038\/s43586-023-00249-4.","journal-title":"Nat Rev Methods Primers"},{"issue":"10","key":"7761_CR3","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/aje\/kwad135","volume":"192","author":"P Sheridan","year":"2023","unstructured":"Sheridan P, Chen C, Thompson CA, Benmarhnia T. Immortal time bias with time-varying exposures in environmental epidemiology: a case study in lung cancer survival. Am J Epidemiol. 2023;192(10):1754\u201362. https:\/\/doi.org\/10.1093\/aje\/kwad135.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"7761_CR4","doi-asserted-by":"publisher","first-page":"E243379","DOI":"10.1001\/jamanetworkopen.2024.3379","volume":"7","author":"AD Sherry","year":"2024","unstructured":"Sherry AD, Hahn AW, Mccaw ZR, et al. Differential treatment effects of subgroup analyses in phase 3 oncology trials from 2004 to 2020. JAMA Netw Open. 2024;7(3):E243379. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.3379.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"7761_CR5","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/sim.10045","volume":"43","author":"JF Troendle","year":"2024","unstructured":"Troendle JF, Leifer ES, Yang S, et al. Use of win time for ordered composite endpoints in clinical trials. Stat Med. 2024;43(10):1920\u201332. https:\/\/doi.org\/10.1002\/sim.10045.","journal-title":"Stat Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07761-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07761-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07761-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:21:32Z","timestamp":1778649692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07761-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7761"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07761-7","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"11 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}